Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2010
06/03/2010WO2010062065A2 Novel nitrogen-containing heterocyclic compound and organic electronic device using the same
06/03/2010WO2010061989A1 Organometallic complex compounds for photoelectric device and photoelectric device including the same
06/03/2010WO2010061903A1 Pyrimidine derivative and pyridine derivative both having pi3k inhibitory activity
06/03/2010WO2010060703A1 3-(benzylamino)-pyrrolidine derivatives and their use as nk-3 receptor antagonists
06/03/2010WO2010009210A3 Acetylsalicyclic acid derivatives useful to treat metabolic syndromes
06/03/2010WO2010005692A4 Insecticidal cyclic carbonyl amidines
06/03/2010WO2009061652A8 Compounds which modulate the cb2 receptor
06/03/2010US20100137590 N[S(4-ARYL-TRIAZOL-3-YL)alpha-MERCAPTOACETYL] -P-AMINO BENZOIC ACIDS AS HIV REVERSE TRANSCRIPTASE INHIBITORS
06/03/2010US20100137583 Peptidomimetic protease inhibitors
06/03/2010US20100137354 Derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine and uses thereof
06/03/2010US20100137329 Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same as inhibitors of the faah enzyme
06/03/2010US20100137324 Rho-kinase inhibitors
06/03/2010US20100137322 Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
06/03/2010US20100137317 1,2-Disubstituted Heterocyclic Compounds
06/03/2010US20100137312 Novel aromatic heterocyclic carboxylic acid amide derivatives useful as potassium channel modulators
06/03/2010US20100137308 Quinoxaline Compounds and Use Thereof
06/03/2010US20100137305 Aminopyrimidines useful as kinase inhibitors
06/03/2010US20100137285 Small molecule modulators of cytokine activity
06/03/2010US20100137280 Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
06/03/2010US20100137275 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
06/03/2010US20100137268 Phthalazinone modulators of h1 receptors and/or ltc4 receptors
06/03/2010US20100136524 Target protein and target gene in drug designing and screening method
06/03/2010US20100136136 JAK-2 Modulators and Methods of Use
06/03/2010US20100135954 6-Phenylpyrimidinones as PIM Modulators
06/03/2010CA2743018A1 Substituted pyrazole compounds
06/03/2010CA2742568A1 Novel cc-1065 analogs and their conjugates
06/03/2010CA2742539A1 Disubstituted phthalazine hedgehog pathway antagonists
06/03/2010CA2742463A1 3-(benzylamin0)-pyrr0lidine derivatives and their use as nk-3 receptor antagonists
06/02/2010EP2192116A1 Indazole acrylic acid amide compound
06/02/2010EP2191832A1 Quinazoline derivatives which promote the release of parathyroid hormone
06/02/2010EP2190837A1 4-pyrimidinesulfamide derivative
06/02/2010EP2190835A1 Adrenergic compounds
06/02/2010EP2190826A2 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
06/02/2010EP2190825A1 5- (4- (haloalkoxy) phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors
06/02/2010EP2190824A1 Naphthylpyrimidine, naphthylpyrazine and naphthylpyridazine analogs and their use as agonists of the wnt-beta-catenin cellular messaging system
06/02/2010EP2190815A1 Pyrrolidine aryl-ether as nk3 receptor antagonists
06/02/2010EP1745040B9 Azabicyclo(3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
06/02/2010EP1483228B1 Nk1 antagonists
06/02/2010EP1417200B1 Substituted 1h-dihydropyrazoles, their preparation and use
06/02/2010CN1938280B Thiourea compositions and uses thereof
06/02/2010CN1826336B Cyclohexanecarboxylic acid compound
06/02/2010CN1809559B Pyrazole derivatives as phosphodiesterase 4 inhibitors
06/02/2010CN101720323A Compounds with anti-cancer activity
06/02/2010CN101720318A Quinazolin-oxime derivatives as hsp90 inhibitors
06/02/2010CN101717396A Triazine type photonic functional material and preparation and application method thereof
06/02/2010CN101250184B Method for synthesizing 1-(2-pyrimidine) piperazine
06/01/2010US7728150 N-[3-(1-Ethyl-5-fluoro-indan-1-yl)-1H-indol-7-yl]-methanesulfonamide; for treating congestive heart disease, hypertension, and atherosclerosis
06/01/2010US7728139 for use as latent pigments; photocopiers
06/01/2010US7728135 such as 4-[4-[(R)-[1-[cyclopropylsulfonyl)-4-piperidinyl](3-fluorophenyl)methyl]-3(S)-methyl-1-piperazinyl]-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]-4-methylpiperidine; chemokine receptors (CCR5)
06/01/2010US7728131 Amide derivative and medicine
06/01/2010US7728031 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
06/01/2010US7728029 hydroxysteroid reductase inhibitors such as 2'-tert-butyl-2'H-[1,3']bipyrazolyl-4'-carboxylic acid (5-hydroxy-adamantan-2-yl)-amide, used for the treatment of non-insulin dependent diabetes mellitus and metabolic syndrome
06/01/2010US7728024 Metal salts of 2′-(1H-Tetrazol-5yl)-1.1′-biphenyl-4-carboxaldehyde
06/01/2010US7728022 (4, 5, 6, 7-tetrahydro-1-H-indol-7-yl) acetic acid derivatives for treatment of Alzheimer's disease
06/01/2010US7728018 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-HT6 antagonists
06/01/2010US7727997 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives
06/01/2010US7727992 2-(3-Ethyl-ureido)-6-pyridin-3-yl-3H-benzoimidazole-4-carboxylic acid methyl ester; for treating bacterial infections in mammals; useful in treating or lessening severity of urinary tract infections, pneumonia, prostatitis, skin and soft tissue infections, intra-abdominal infections
06/01/2010US7727989 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments
06/01/2010CA2448737C Viral polymerase inhibitors
06/01/2010CA2352524C Aromatic heterocyclic compounds as antiinflammatory agents
05/2010
05/27/2010WO2010059773A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
05/27/2010WO2010059611A2 Inhibitors of diacylglycerol acyltransferase
05/27/2010WO2010059393A1 Serotonin receptor modulators
05/27/2010WO2010058858A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/27/2010WO2010058353A1 Novel bis-amides as antimalarial agents
05/27/2010WO2010058032A2 New compounds
05/27/2010WO2010058030A1 New compounds
05/27/2010WO2010038081A3 4-amino-5- (hetero) aryl-2-phenylamino-pyrimidine or pyridine and their use as dna gyrase and/or topoisomerase iv inhibitors
05/27/2010WO2010036638A3 Compounds for the treatment of inflammatory disorders
05/27/2010WO2010013222A8 Pyrrole carboxylic acid derivatives as antibacterial agents
05/27/2010WO2010001041A3 Cosmetic composition method for cosmetic treatment and 4-oxo-1, 4-dihydr0pyrimidin-2-yl compounds
05/27/2010WO2009153178A3 Aryl ketone as mri
05/27/2010WO2009140624A3 Glucokinase activators
05/27/2010US20100130738 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
05/27/2010US20100130513 Benzimidazoles and analogs thereof as antivirals
05/27/2010US20100130509 Novel antibiotics
05/27/2010US20100130506 Organic Compounds
05/27/2010US20100130505 Compositions and methods for inhibiting g protein signaling
05/27/2010US20100130501 Novel 3-amino-pyrrolo[3,4-c]pyrazole-5(1h, 4h, 6h) carbaldehyde derivatives
05/27/2010US20100130486 Cyclic amine substituted pyrimidinediamines as pkc inhibitors
05/27/2010US20100130476 Compounds that induce pancreatic beta-cell expansion
05/27/2010US20100130474 Alpha7 nicotinic acetylcholine receptor inhibitors
05/27/2010US20100130468 Indole carboxamides as ikk2 inhibitors
05/27/2010US20100130447 Inhibitors of kinase activity
05/27/2010US20100130446 Nitrogen-containing five-membered heterocyclic compound
05/27/2010US20100130440 Antiviral nucleosides
05/27/2010US20100129473 AMINO SUBSTITUTED DIARYL[a,d]CYCLOHEPTENE ANALOGS AS MUSCARINIC AGONISTS AND METHODS OF TREATMENT OF NEUROPSYCHIATRIC DISORDERS
05/27/2010US20100129293 Near Infrared Imaging Agent
05/27/2010US20100127616 Compound for organic electroluminescent device and organic electroluminescent device
05/27/2010CA2744351A1 New compounds
05/27/2010CA2743562A1 Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
05/27/2010CA2743497A1 Inhibitors of diacylglycerol acyltransferase
05/27/2010CA2742903A1 Novel bis-amides as antimalarial agents
05/27/2010CA2741511A1 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
05/26/2010EP2189457A1 Novel synthesis of irbesartan
05/26/2010EP2189449A1 Aminopyrazole amide derivative
05/26/2010EP2188279A2 1,3 and 1,3,5 substituted imidazoles as antihypertensiva
05/26/2010EP2188278A1 Phthalazinone derivatives
05/26/2010EP2188277A1 Quinazolinedione chymase inhibitors
05/26/2010EP2188276A1 Substituted hydantoins